6UQU
Serendipitous Discovery of Aryl Boronic Acids as beta-Lactamase Inhibitors
Summary for 6UQU
Entry DOI | 10.2210/pdb6uqu/pdb |
Descriptor | Beta-lactamase, PHENYL BORONIC ACID, CHLORIDE ION, ... (4 entities in total) |
Functional Keywords | boronic acid inhibitors, drug resistance, antibiotic |
Biological source | Pseudomonas aeruginosa |
Total number of polymer chains | 1 |
Total formula weight | 41181.70 |
Authors | Scapin, G. (deposition date: 2019-10-21, release date: 2019-10-30, Last modification date: 2024-10-16) |
Primary citation | Yang, S.W.,Pan, J.,Root, Y.,Scapin, G.,Xiao, L.,Su, J. Serendipitous discovery of aryl boronic acids as beta-lactamase inhibitors. Bioorg.Med.Chem.Lett., 30:126795-126795, 2020 Cited by PubMed Abstract: High throughput screening for β-lactamase inhibitors afforded biphenyl hits such as 1. Hit confirmation and X-ray soaking experiments with Pseudomonas Aeruginosa AmpC enzyme led to the identification of an aryl boronic acid-serine complex 4, which was formed from phenyl boronic acid 8 (an impurity in compound 1) and ethylene glycol (the cryoprotectant in the soaking experiment). PubMed: 31759850DOI: 10.1016/j.bmcl.2019.126795 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.0902 Å) |
Structure validation
Download full validation report